1. Study protocol for SPARED trial: randomised non-inferiority phase III trial comparing dexamethasone on day 1 with dexamethasone on days 1–4, combined with neurokinin-1 receptor antagonist, palonosetron and olanzapine (5 mg) in patients receiving cisplatin-based chemotherapy. Issue 12 (17th December 2020) Authors: Minatogawa, Hiroko; Izawa, Naoki; Kawaguchi, Takashi; Miyaji, Tempei; Shimomura, Kazuhiro; Kazunori, Honda; Iihara, Hirotoshi; Ohno, Yasushi; Inada, Yusuke; Arioka, Hitoshi; Morita, Hajime; Hida, Naoya; Sugawara, Mitsuhiro; Katada, Chikatoshi; Nawata, Shuichi; Ishida, Hiroo; Tsuboya, Ayako; Tsuda... Journal: BMJ open Issue: Volume 10:Issue 12(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Study protocol for SPARED trial: randomised non-inferiority phase III trial comparing dexamethasone on day 1 with dexamethasone on days 1–4, combined with neurokinin-1 receptor antagonist, palonosetron and olanzapine (5 mg) in patients receiving cisplatin-based chemotherapy. Issue 12 (17th December 2020) Authors: Minatogawa, Hiroko; Izawa, Naoki; Kawaguchi, Takashi; Miyaji, Tempei; Shimomura, Kazuhiro; Kazunori, Honda; Iihara, Hirotoshi; Ohno, Yasushi; Inada, Yusuke; Arioka, Hitoshi; Morita, Hajime; Hida, Naoya; Sugawara, Mitsuhiro; Katada, Chikatoshi; Nawata, Shuichi; Ishida, Hiroo; Tsuboya, Ayako; Tsuda... Journal: BMJ open Issue: Volume 10:Issue 12(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Study protocol for SPARED trial: randomised non-inferiority phase III trial comparing dexamethasone on day 1 with dexamethasone on days 1–4, combined with neurokinin-1 receptor antagonist, palonosetron and olanzapine (5 mg) in patients receiving cisplatin-based chemotherapy. Issue 12 (17th December 2020) Authors: Minatogawa, Hiroko; Izawa, Naoki; Kawaguchi, Takashi; Miyaji, Tempei; Shimomura, Kazuhiro; Kazunori, Honda; Iihara, Hirotoshi; Ohno, Yasushi; Inada, Yusuke; Arioka, Hitoshi; Morita, Hajime; Hida, Naoya; Sugawara, Mitsuhiro; Katada, Chikatoshi; Nawata, Shuichi; Ishida, Hiroo; Tsuboya, Ayako; Tsuda... Journal: BMJ open Issue: Volume 10:Issue 12(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Study protocol for SPARED trial: randomised non-inferiority phase III trial comparing dexamethasone on day 1 with dexamethasone on days 1–4, combined with neurokinin-1 receptor antagonist, palonosetron and olanzapine (5 mg) in patients receiving cisplatin-based chemotherapy. Issue 12 (17th December 2020) Authors: Minatogawa, Hiroko; Izawa, Naoki; Kawaguchi, Takashi; Miyaji, Tempei; Shimomura, Kazuhiro; Kazunori, Honda; Iihara, Hirotoshi; Ohno, Yasushi; Inada, Yusuke; Arioka, Hitoshi; Morita, Hajime; Hida, Naoya; Sugawara, Mitsuhiro; Katada, Chikatoshi; Nawata, Shuichi; Ishida, Hiroo; Tsuboya, Ayako; Tsuda... Journal: BMJ open Issue: Volume 10:Issue 12(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Study protocol for SPARED trial: randomised non-inferiority phase III trial comparing dexamethasone on day 1 with dexamethasone on days 1–4, combined with neurokinin-1 receptor antagonist, palonosetron and olanzapine (5 mg) in patients receiving cisplatin-based chemotherapy. Issue 12 (17th December 2020) Authors: Minatogawa, Hiroko; Izawa, Naoki; Kawaguchi, Takashi; Miyaji, Tempei; Shimomura, Kazuhiro; Kazunori, Honda; Iihara, Hirotoshi; Ohno, Yasushi; Inada, Yusuke; Arioka, Hitoshi; Morita, Hajime; Hida, Naoya; Sugawara, Mitsuhiro; Katada, Chikatoshi; Nawata, Shuichi; Ishida, Hiroo; Tsuboya, Ayako; Tsuda... Journal: BMJ open Issue: Volume 10:Issue 12(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗